Patents by Inventor Dimitry M. Danilenko

Dimitry M. Danilenko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATMENT OF MICROBIAL DISORDERS
    Publication number: 20210338778
    Abstract: The present invention relates to compositions and methods for treatment of microbial disorder by modulation of the host immune response. More particularly, the present invention relates to compositions that mediate an anti-microbial immune response, and methods of treating a microbial infection using such compositions.
    Type: Application
    Filed: January 29, 2021
    Publication date: November 4, 2021
    Inventors: Alexander R. ABBAS, Nico P. GHILARDI, Zora MODRUSAN, Dimitry M. DANILENKO, Frederic J. DE SAUVAGE, Wenjun OUYANG, Patricia A. VALDEZ, Yan ZHENG
  • METHODS FOR TREATMENT OF MICROBIAL DISORDERS
    Publication number: 20130052159
    Abstract: The present invention relates to compositions and methods for treatment of microbial disorder by modulation of the host immune response. More particularly, the present invention relates to compositions that mediate an anti-microbial immune response, and methods of treating a microbial infection using such compositions.
    Type: Application
    Filed: August 3, 2012
    Publication date: February 28, 2013
    Inventors: Alexander R. Abbas, Nico P. Ghilardi, Zora Modrusan, Dimitry M. Danilenko, Frederic J. De Sauvage, Wenjun Ouyang, Patricia A. Valdez, Yan Zheng
  • METHODS FOR TREATMENT OF MICROBIAL DISORDERS
    Publication number: 20110280828
    Abstract: The present invention relates to compositions and methods for treatment of microbial disorder by modulation of the host immune response. More particularly, the present invention relates to compositions that mediate an anti-microbial immune response, and methods of treating a microbial infection using such compositions.
    Type: Application
    Filed: May 20, 2011
    Publication date: November 17, 2011
    Inventors: Alexander R. ABBAS, Nico P. Ghilardi, Zora Modrusan, Dimitry M. Danilenko, Frederic J. De Sauvage, Wenjun Ouyang, Patricia A. Valdez, Yan Zheng
  • NUCLEIC ACID MOLECULES ENCODING BETA-LIKE GLYCOPROTEIN HORMONE POLYPEPTIDE AND HETERODIMER THEREOF
    Publication number: 20100255537
    Abstract: Novel ?10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing ?10 polypeptides and heterodimeric forms thereof, specifically ?2/?10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with ?10 polypeptides and ?2/?10 heterodimers or their respective binding agents.
    Type: Application
    Filed: June 16, 2010
    Publication date: October 7, 2010
    Inventors: Christopher J. R. Paszty, Jin Cao, Dimitry M. Danilenko, Jianhua Gong, David C. Hill
  • Compositions and methods for treatment of microbial disorders
    Publication number: 20090202475
    Abstract: The present invention relates to compositions and methods for treatment of microbial disorder by modulation of the host immune response. More particularly, the present invention relates to compositions that mediate an anti-microbial immune response, and methods of treating a microbial infection using such compositions.
    Type: Application
    Filed: November 7, 2008
    Publication date: August 13, 2009
    Applicant: Genentech, Inc.
    Inventors: Alexander R. Abbas, Nico P. Ghilardi, Zora Modrusan, Dimitry M. Danilenko, Frederic J. De Sauvage, Wenjun Ouyang, Patricia A. Valdez, Yan Zheng
  • Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
    Patent number: 7514239
    Abstract: Novel ?10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing ?10 polypeptides and heterodimeric forms thereof, specifically ?2/?10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with ?10 polypeptides and ?2/?10 heterodimers or their respective binding agents.
    Type: Grant
    Filed: March 27, 2001
    Date of Patent: April 7, 2009
    Assignee: Amgen Inc.
    Inventors: Christopher J. R. Paszty, Jin Cao, Dimitry M. Danilenko, Jianhua Gong, David C. Hill
  • Beta-like glycoprotein hormone polypeptide and heterodimer
    Publication number: 20080188417
    Abstract: Novel ?10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing ?10 polypeptides and heterodimeric forms thereof, specifically ?2/?10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with ?10 polypeptides and ?2/?10 heterodimers or their respective binding agents.
    Type: Application
    Filed: February 27, 2008
    Publication date: August 7, 2008
    Inventors: Christopher J. R. Paszty, Jin Cao, Dimitry M. Danilenko, Jianhua Gong, David C. Hill
  • Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
    Publication number: 20080166768
    Abstract: Novel ?10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing ?10 polypeptides and heterodimeric forms thereof, specifically ?2/?10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with ?10 polypeptides and ?2/?10 heterodimers or their respective binding agents.
    Type: Application
    Filed: February 27, 2008
    Publication date: July 10, 2008
    Inventors: Chirstopher J. R. Paszty, Jin Cao, Dimitry M. Danilenko, Jianhua Gong, David C. Hill
  • Beta-like glycoprotein hormone polypeptide and heterodimer
    Patent number: 7358341
    Abstract: Novel ?10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing ?10 polypeptides and heterodimeric forms thereof, specifically ?2/?10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with ?10 polypeptides and ?2/?10 heterodimers or their respective binding agents.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: April 15, 2008
    Assignee: Amgen Inc.
    Inventors: Christopher J. R. Paszty, Jin Cao, Dimitry M. Danilenko, Jianhua Gong, David C. Hill
  • BETA-LIKE GLYCOPROTEIN HORMONE POLYPEPTIDE AND HETERODIMER
    Publication number: 20080057515
    Abstract: Novel ?10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing ?10 polypeptides and heterodimeric forms thereof, specifically ?2/?10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with ?10 polypeptides and ?2/?10 heterodimers or their respective binding agents.
    Type: Application
    Filed: May 28, 2003
    Publication date: March 6, 2008
    Inventors: Christopher J. R. Paszty, Jin Cao, Dimitry M. Danilenko, Jianhua Gong, David C. Hill
  • Beta-like glycoprotein hormone polypeptide and heterodimer
    Publication number: 20030207403
    Abstract: Novel &bgr;10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing &bgr;10 polypeptides and heterodimeric forms thereof, specifically &agr;2/&bgr;10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with &bgr;10 polypeptides and &agr;2/&bgr;10 heterodimers or their respective binding agents.
    Type: Application
    Filed: May 28, 2003
    Publication date: November 6, 2003
    Applicant: Amgen Inc.
    Inventors: Christopher J. R. Paszty, Jin Cao, Dimitry M. Danilenko, Jianhua Gong, David C. Hill
  • Uses of keratinocyte growth factor-2
    Publication number: 20030144202
    Abstract: The present invention concerns the use of a KGF-2 protein(s) as a therapeutic agent, suitably formulated in a pharmaceutical composition, for the specific treatment of disease states and medical conditions afflicting tissues and organs such as in the eye, ear, gums, pancreas, urinary bladder, liver and gastrointestinal tract.
    Type: Application
    Filed: December 5, 2002
    Publication date: July 31, 2003
    Applicant: Amgen Inc.
    Inventors: David L. Lacey, Thomas R. Ulich, Dimitry M. Danilenko, Catherine L. Farrell
  • Beta-like glycoprotein hormone polypeptide and heterodimer
    Publication number: 20020015981
    Abstract: Novel &bgr;10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing &bgr;10 polypeptides and heterodimeric forms thereof, specifically &agr;2/&bgr;10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with &bgr;10 polypeptides and &agr;2/&bgr;10 heterodimers or their respective binding agents.
    Type: Application
    Filed: March 27, 2001
    Publication date: February 7, 2002
    Inventors: Christopher J.R. Paszty, Jin Cao, Dimitry M. Danilenko, Jianhua Gong, David C. Hill